← Back to Screener
Kenvue Inc. (KVUE)
Price$17.71
Value ScoreC
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-5.85%
Price vs S&P 500 (4W)0.69%
VGM Score53.11
Market Capitalization$34.00B
P/E Ratio (Annual)23.13x
Indicated Dividend Yield (Annual)4.92%
All Metrics
P/CF (Annual)15.48x
Book Value / Share (Quarterly)$5.53
P/TBV (Annual)15.90x
Indicated Dividend (Annual)$0.83
Revenue Growth (3Y)0.39%
Cash Flow / Share (Quarterly)$0.95
Payout Ratio (TTM)97.84%
Price vs S&P 500 (YTD)-5.49%
Gross Margin (TTM)58.85%
Net Profit Margin (TTM)10.61%
EPS (TTM)$0.84
10-Day Avg Trading Volume22.53M
EPS Excl Extra (TTM)$0.84
Revenue Growth (5Y)0.89%
EPS (Annual)$0.76
Dividend / Share (Annual)$0.83
ROI (Annual)7.62%
Gross Margin (Annual)58.62%
Net Profit Margin (5Y Avg)10.92%
Cash / Share (Quarterly)$0.56
P/E Basic Excl Extra (TTM)20.96x
Revenue Growth QoQ (YoY)4.49%
P/E Normalized (Annual)23.13x
ROA (Last FY)5.43%
Revenue Growth TTM (YoY)-0.07%
EBITD / Share (TTM)$1.66
ROE (5Y Avg)11.91%
Operating Margin (TTM)17.15%
Cash Flow / Share (Annual)$0.90
P/B Ratio3.21x
P/B Ratio (Quarterly)3.12x
Net Income / Employee (Annual)$67,500
EV / Revenue (TTM)2.72x
Net Interest Coverage (TTM)5.70x
ROA (TTM)5.99%
EPS Growth QoQ (YoY)47.40%
EV / EBITDA (TTM)13.05x
EPS Incl Extra (Annual)$0.76
Current Ratio (Annual)0.96x
Quick Ratio (Quarterly)0.63x
3-Month Avg Trading Volume28.81M
52-Week Price Return-18.20%
EV / Free Cash Flow (Annual)24.15x
P/E Incl Extra (TTM)20.96x
Revenue / Employee (TTM)$702,100
Tangible BV / Share (Quarterly)$1.08
P/S Ratio (Annual)2.25x
Asset Turnover (Annual)0.56x
52-Week High$22.87
Operating Margin (5Y Avg)16.32%
EPS Excl Extra (Annual)$0.76
CapEx CAGR (5Y)15.71%
26-Week Price Return2.07%
Quick Ratio (Annual)0.61x
13-Week Price Return-2.96%
Total Debt / Equity (Annual)0.79x
Current Ratio (Quarterly)0.98x
Enterprise Value$41.59B
Revenue / Share Growth (5Y)0.52%
Asset Turnover (TTM)0.56x
Revenue / Employee (Annual)$694,400
Inventory Turnover (Annual)3.84x
Pretax Margin (Annual)13.22%
Cash / Share (Annual)$0.55
3-Month Return Std Dev21.56%
Gross Margin (5Y Avg)57.11%
Net Income / Employee (TTM)$74,500
ROE (Last FY)13.66%
Net Interest Coverage (Annual)6.56x
EPS Basic Excl Extra (Annual)$0.76
P/FCF (TTM)18.65x
Receivables Turnover (TTM)6.35x
EV / Free Cash Flow (TTM)22.81x
Total Debt / Equity (Quarterly)0.82x
EPS Incl Extra (TTM)$0.84
Receivables Turnover (Annual)6.65x
ROI (TTM)8.37%
P/S Ratio (TTM)2.22x
Pretax Margin (5Y Avg)14.73%
Revenue / Share (Annual)$7.86
Tangible BV / Share (Annual)$1.08
Forward P/E14.15x
Free OCF CAGR (5Y)-11.48%
Price vs S&P 500 (52W)-42.56%
P/E Ratio (TTM)20.96x
EPS Growth TTM (YoY)53.73%
Year-to-Date Return2.67%
5-Day Price Return2.07%
EPS Normalized (Annual)$0.76
ROA (5Y Avg)6.07%
Net Profit Margin (Annual)9.72%
Month-to-Date Return2.49%
EBITD / Share (Annual)$1.54
EPS Growth (3Y)-11.57%
Operating Margin (Annual)15.96%
LT Debt / Equity (Annual)0.64x
P/CF (TTM)15.06x
ROI (5Y Avg)8.43%
P/E Excl Extra (TTM)20.96x
LT Debt / Equity (Quarterly)0.67x
EPS Basic Excl Extra (TTM)$0.84
P/TBV (Quarterly)16.01x
Payout Ratio (Annual)107.55%
P/B Ratio (Annual)3.06x
Dividend / Share (TTM)$0.83
Inventory Turnover (TTM)3.75x
Pretax Margin (TTM)14.47%
Book Value / Share (Annual)$5.62
Price vs S&P 500 (13W)-11.21%
Dividend Yield (TTM)4.67%
Beta0.49x
P/FCF (Annual)19.75x
Revenue / Share (TTM)$7.96
ROE (TTM)15.18%
52-Week Low$14.02
vGradeC
gGradeC
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.32est. 0.27
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
2.75
2.75
2.75
2.72
Industry Peers — Cosmetics & Toiletries(19)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
KVUEKenvue Inc. | C | C | C | $17.71 |
| CLColgate-Palmolive Company | C | C | C | $88.58 |
| HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares) | B | B | C | $9.12 |
| ELThe Estee Lauder Companies Inc. Class A | C | D | C | $83.49 |
| ELFe.l.f. Beauty, Inc. | C | B | D | $49.57 |
| IPARInterparfums, Inc. Common Stock | B | B | C | $91.27 |
| COTYCOTY INC | B | C | D | $1.96 |
| OLPXOlaplex Holdings, Inc. Common Stock | C | D | B | $2.04 |
| EPCEdgewell Personal Care Company | B | D | C | $19.87 |
| WALDWaldencast plc Class A Ordinary Share | B | D | C | $1.72 |
| EMPGEmpro Group Inc. Ordinary shares | — | — | A | $17.36 |
About
Kenvue is the world's largest pure-play consumer health company with over $15 billion in annual revenue, offering products across pain management, oral care, cough and cold care, and skincare through iconic brands including Tylenol, Listerine, Aveeno, and Neutrogena. Spun off from Johnson & Johnson in May 2023, the company agreed to be acquired by Kimberly-Clark in November 2025, with the transaction expected to close in the second half of 2026.